Neuropharmacological studies on Fusarium toxins - I: Total toxin extract from Fusarium moniliforme

Indian Journal of Experimental Biology

Volumn 34, Issue 5, 1996, Pages 408-417

  Ganguli, Snigdha ^a   Hota, D ^a   Goel, R K ^a   Acharya, S B ^a   Bhattacharya, S K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMPHETAMINE; APOMORPHINE; CLONIDINE; HALOPERIDOL; LEVODOPA; MORPHINE; NIALAMIDE; PENTETRAZOLE; PENTOBARBITAL; PHENETHYLAMINE; PHENYTOIN; RESERPINE; TETRABENAZINE; TOXIN; TRYPTAMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONVULSION; FEMALE; FUSARIUM MONILIFORME; HYPNOSIS; INTRAPERITONEAL DRUG ADMINISTRATION; LETHALITY; MALE; MOTOR ACTIVITY; MOUSE; NEUROPHARMACOLOGY; NONHUMAN; RAT; SEIZURE;

ANALGESICS; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; FEMALE; FUSARIUM; MALE; MICE; MONOAMINE OXIDASE INHIBITORS; MYCOTOXINS; NIALAMIDE; RATS;

ANIMALIA; FUSARIUM; GIBBERELLA FUJIKUROI; GYMNOMYZA SAMOENSIS; PISUM SATIVUM;

EID: 0029945074     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Shank R C, in Handbook of trace substances and health, Part 1, edited by P M Newberne (Marcel Dekker, New York) 1976, 67.
2. Ghoshal S, Chakrabarti D K & Basuchowdhury K C, J Pharm Sci, 65 (1976) 160.
3. Chakrabarti D K, Basuchowdhury K C & Ghosal S, Experimentia, 32 (1976) 608.
4. Ghoshal S, Biswas K, Srivastava R S, Chakrabarti D K & Basuchowdhury K C, J Pharm Sci, 67 (1978) 1768.
5. Diringer M N, Kramarcy N R, Brown J W & Thurmond J B, Biochemistry and behaviour, 16 (1982) 73.
6. Shillito E, Br J Pharmacol, 40 (1970) 113.
7. Barnett A & Taber R I, in Screening methods in pharmacology, Vol. II, edited by R A Turner & P A Hebborn (Academic Press, New York) 1971, 214.
8. Pertwee R C, Br J Pharmacol, 46 (1972) 753.
9. Davies O L, Raventos J & Walpole A L, Br J Pharmacol Chemother, 1 (1946) 255.
10. Eddy N B & Leimbach D, J Pharmacol Exp Ther, 107 (1953) 385.
11. Mohrland J S & Craigmill A L, Pharmacol Biochem Behav, 12 (1980) 313.
12. Costal B & Naylor R J, Eur J Pharmacol, 18 (1972) 83.
13. Corne S J, Pickering R W & Warner B T, Br J Pharmacol, 20 (1963) 106.
14. Everett C M, in Proceedings of the first international symposium on antidepresant/drugs, edited by S Garratini & H N G Dukes (Excerpta Medica Foundation) 1966, 164.
15. Porsolt R D, Bertin A, Blavet N, Daniel M & Jalfre M, Eur J Pharmacol, 57 (1979) 201.
16. Bhattacharya S K, Datla K P, Indian J Med Res, 90 (1989) 387.
17. Razzak A, Fuziwara M & Ueki S, Jap J Pharmacol, 27 (1977) 145.
18. Chakrabarti D K, in Ph D thesis, Studies on some aspects of fusarium induced plant diseases and their remedy (Bidhan Chandra Krishi Viswavidyalaya, West Bengal) 1981.
19. Bhattacharya S, in Ph D thesis, Investigation on fungal toxin with special reference to Central Nervous System (Banaras Hindu University, Varanasi) 1988, 84.
20. Mukhopadhyay M, Upadhyay S N & Bhattacharya S K, Indian J Exp Biol, 25 (1987) 761.
21. Neuropsychopharmacology of monoamines and their regulatory enzymes: Adances in Biochemical Pharmacology, Vol. 12, edited by E Usdin (Raven Press, New York) 1974.
22. Berger P A & Barchas J D, in Monoamine oxidase inhibitors in psyshotherapeutic drugs, edited by E Usdin & I Forrest (Dekker, New York) 1977.
23. Baldessarini R J, in Disease a month: Mood drugs, Vol. 24(2), edited by H F Dowling (Yearbook Medical Publishers, Chicago) 1977.
24. Knoll J, in Monoamine oxidase and its inhibition, edited by G E W Wolstenholme & J Knight (Elsevier, North Holland) 1976, 135.
25. Kline N S & Cooper T B, in Psychotropic agents, Part I: Antipsychotics and antidepressants, edited by F Hoffmeister & G Stille (Springer Verlag, Berlin) 1980, 372.
26. Bhattacharya S K, Denbath P K, Mukhopadhyay S N & Das P K, Indian J Pharmacol, 17 (1975) 35.
27. Bhattacharya S K, Bose R & Ghosh P, Materia Med Polona, 10 (1978) 194.
28. Bhattacharya S K, Reddy P K S P & Das P K, in Drugs & Central synaptic transmission, edited by P B Bradley & B N Dhawan (Macmillan, London) 1976, 155.
29. Bhattacharya S K, Ghosh P & Bose R, Materia Med Polona, 10 (1978) 184.
30. Tadeschi D H, Fowler P J, Fujita P & Miller R B, Life Sci, 6 (1967) 515.
31. Youdim M B H & Finberg J P M, in Monoamine oxidase and its selective inhibitors, edited by H Beckmann, & P Riederer (S Karger, Basel) 1983, 63.
32. Fuenmayor L & Vogt M, Proct Int Physiol Sci, 8 (1977) 245.
33. Messing R B & Lytle L D, Pain, 4 (1977) 1.
34. Radauco-Thomas S, Singh P, Garcia P & Radauco-Thomas C, Arch Biol Med Exp, 4 (1967) 42.
35. Lomax P, Int Rev Neurobiol, 12 (1970) 1.
36. Mathysse S & Sugarman J, in Handbook of psychopharmacology, Vol. 10, edited by L L Iversen, S D Iversen & S H Snyder (Plenum Press, New York) 1978, 221.
37. Jacob J J & Girault J T, in Body temperature, regulation, drug effects and therapeutic implications, edited by P Lomax & E Schonbaum (Marcel Dekker, New York) 1979, 183.
38. Iversen L L & Bloom F E, Neurosci Res Prog Bull, 8 (1970) 407.
39. Fog R, Acta Neurol Scand, 48 (Suppl 50) 1972, 1.
40. Eichelmann B, in Psychopharmacology of aggression, edited by M Sandleer (Raven Press, New York) 1979, 61.
41. Bhattacharya S K, Jaiswal A K, Mukhopadhyay M & Datla K P, J Psychiat Res, 22 (1983) 43.
42. Bhattacharya S K, Natn Med J India, 6 (1993) 80.